United States, green light for the vaccine is ready for ages 12 and up
Covid-19 vaccines will soon be available in Usa also for the children: US regulators on Monday extended the use of the serum Pfizer to those of just 12 anni, sparking a race to protect middle and high school students before they return to class in the fall. Vaccinations could begin as soon as a federal vaccine advisory committee issues recommendations for the use of the two-dose vaccine in children of age between 12 and 15 years: the decision is expected Wednesday. Vaccinating children of all ages will be essential to return to normal. Most Covid-19 vaccines distributed around the world have been licensed for adults. Pfizer’s vaccine is used in multiple countries for teens as young as 16, and Canada was recently the first to extend its use to 12 and beyond. “This is a turning point in our ability to fight the Covid-19 pandemic,” he told The Associated Press. Bill Gruber, senior vice president of Pfizer and also a pediatrician. The Food and Drug Administration has stated that the Pfizer vaccine is safe and offers one strong protection for young teenagers based on tests on over 2,000 US volunteers aged 12 to 15. The study found no cases of Covid-19 among fully vaccinated teens compared to 18 among children.
The US has over 261 million doses already injected
In the United States Approximately 262 million doses of the Covid-19 vaccine have been administered. This is revealed by data published by the US Centers for Disease Control and Prevention (CDC), according to which exactly 261,599,381 total doses were injected, equal to about 79 percent of the 329,843,825 delivered. This is about 1.9 million doses administered more than in the previous survey, for a weekly average of approximately 2.1 million doses per day. About the 46 percent of the population – 153 million people – received at least one dose of vaccine and the 34.8 percent of the population – about 116 million people – was fully immunized.
Distribution of AstraZeneca produced in Mexico and Argentina will start at the end of the month
The government of the Mexico announced that the 18 million doses of the Covid vaccine of Oxford-AstraZeneca produced to date in Argentina from the laboratory mAbxience and remained stuck for months in Mexico waiting to be stored, will begin to be distributed in the region in late May. This was announced by the Foreign Minister, Marcelo Ebrard, through a message on his Twitter profile. “The first batches of the vaccine have already been packaged and will be available this month for administration”, wrote Ebrard, also announcing the arrival from Buenos Aires of another 5.7 million doses to be potted. In August 2020, AstraZeneca and the University of Oxford announced that two Latin American laboratories they would be tasked with producing between 150 and 250 million doses of their vaccine to be distributed in the region within the first half of this year. The Argentine mAbxience, would produce the active substance of the doses and the Mexican laboratory Liomont would complete the finishing and packaging process. The agreement between the parties provided that the cost of financing the production would be assumed by the foundation of the Mexican telecommunications magnate, Carlos Slim. While the Argentine laboratory started production on time and started sending the active ingredient in February, the Mexican counterpart ran into supply difficulties that have delayed the packaging process until today.